Brandon Hogstad, PhD is an AI-implementation consultant who helps executives and product teams put generative AI to work. Drawing on a deep research and early-stage innovation background, Brandon excels at distilling complex science and technology into clear, practical tools and playbooks that drive immediate results.
Through his firm Morpheos Innovation, Brandon also serves as a consultant and entrepreneur-in-residence, guiding venture-backed startups and academic spin-outs across biotech, health-tech, and deep-tech. He specializes in strategic commercialization, partnerships, competitive intelligence, and scientific due diligence—bridging the gap between cutting-edge research and market-ready products.
Previously, he built drug-discovery accelerator programs at NYU Langone Health, forging collaborations with Sanofi and Pfizer (contributing research that informed Paxlovid). He later led AI-driven immunotherapy initiatives at Immunai, harnessing machine learning and single-cell genomics for precision medicine.
Brandon earned his PhD in Biomedical Sciences from the Icahn School of Medicine at Mount Sinai; his work has appeared in Nature and the Journal of Experimental Medicine. Outside of consulting and coaching, he co-hosts the dream-interpretation podcast Let's Talk About Dreams and releases music with his brother as The Hogstad Brothers.